Last reviewed · How we verify

Ophthalmic Insert — Competitive Intelligence Brief

Ophthalmic Insert (Ophthalmic Insert) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Ophthalmic insert / sustained-release device. Area: Ophthalmology.

phase 3 Ophthalmic insert / sustained-release device Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Ophthalmic Insert (Ophthalmic Insert) — Ocular Therapeutix, Inc.. An ophthalmic insert that delivers medication directly to the eye to treat ocular surface disease and inflammation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ophthalmic Insert TARGET Ophthalmic Insert Ocular Therapeutix, Inc. phase 3 Ophthalmic insert / sustained-release device

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Ophthalmic insert / sustained-release device class)

  1. Ocular Therapeutix, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ophthalmic Insert — Competitive Intelligence Brief. https://druglandscape.com/ci/ophthalmic-insert. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: